BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8302462)

  • 1. Calcium mass transfer in CAPD: the role of convective transport.
    Montenegro J; Saracho R; Aguirre R; Martinez I
    Nephrol Dial Transplant; 1993; 8(11):1234-6. PubMed ID: 8302462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium mass transfer and kinetics in CAPD using calcium-free solutions.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1993; 9():274-9. PubMed ID: 8105942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium mass transfer with 10-hour dwell time using 1.25 versus 1.75 mmol/L calcium dialysate.
    Banalagay EE; Bernardini J; Piraino B
    Adv Perit Dial; 1993; 9():271-3. PubMed ID: 8105941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid.
    Merchant MR; Hutchinson AJ; Butler SJ; Boulton H; Hintchliffe R; Gokal R
    Adv Perit Dial; 1992; 8():365-8. PubMed ID: 1361824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium balance and serum ionized calcium fluctuations in on-line haemodiafiltration in relation to ultrafiltration rate and dialysate calcium concentration.
    Malberti F; Corradi B; Tetta C; Imbasciati E
    Nephrol Dial Transplant; 1994; 9(12):1759-64. PubMed ID: 7708260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis.
    Krediet RT; Boeschoten EW; Zuyderhoudt FM; Arisz L
    Clin Nephrol; 1987 Feb; 27(2):51-5. PubMed ID: 3829478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measuring ionized calcium (Ca2+) transport during intermittent peritoneal dialysis (IPD)].
    Grzegorzewska A; Chalama B; Mariak I; Kupsz J
    Przegl Lek; 1997; 54(5):302-7. PubMed ID: 9380803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrafiltration capacity and peritoneal fluid kinetics in continuous ambulatory peritoneal dialysis patients.
    Zhe XW; Tian XK; Cheng L; Wang T
    Artif Organs; 2008 Jan; 32(1):61-5. PubMed ID: 18181804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium mass transfer in peritoneal dialysis patients using 2.5 mEq/l calcium dialysate.
    Piraino B; Bernardini J; Holley J; Johnston JR; Perlmutter JA; Martis L
    Clin Nephrol; 1992 Jan; 37(1):48-51. PubMed ID: 1541065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relative hypoparathyroidism associated with CAPD treatment using normo-calcemic (3.5mEq/1) dialysate: an approach from transperitoneal calcium balance].
    Shigematsu T; Hasegawa T; Utsunomiya M; Kubo H; Kato N; Hayakawa H; Yamamoto H; Nakayama M; Ogawa A; Kawaguchi Y
    Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):172-8. PubMed ID: 7731105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating peritoneal fluid transport in continuous peritoneal dialysis patients: a practical approach.
    Zhe XW; Tian XK; Shan YS; Cheng L; Wang T
    Nephron Clin Pract; 2007; 107(4):c123-7. PubMed ID: 17957122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemia in patients treated with CAPD.
    Orłowska-Kowalik G; Ksiazek A
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):479-84. PubMed ID: 16146134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysate CA125 in stable CAPD patients: no relation with transport parameters.
    Pannekeet MM; Koomen GC; Struijk DG; Krediet RT
    Clin Nephrol; 1995 Oct; 44(4):248-54. PubMed ID: 8575125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of metabolic acidosis on serum albumin and other nutritional parameters in long-term CAPD patients.
    Kang SW; Lee SW; Lee IH; Kim BS; Choi KH; Lee HY; Han DS
    Adv Perit Dial; 1997; 13():249-52. PubMed ID: 9360692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kinetic of calcium, phosphate, magnesium and PTH variations during hemodiafiltration].
    Rius A; Hernández-Jaras J; Pons R; García Pérez H; Torregrosa E; Sánchez Canel JJ; Fenollosa MA; Pin MT; Tamarit E; Calvo C
    Nefrologia; 2007; 27(5):593-8. PubMed ID: 18045035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of bethanechol chloride to increase available ultrafiltration in CAPD.
    Baranowska-Daca E; Torneli J; Popovich RP; Moncrief JW
    Adv Perit Dial; 1995; 11():69-72. PubMed ID: 8534741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scrotal edema secondary to fluid imbalance in patients on continuous peritoneal dialysis.
    Adeniyi M; Wiggins B; Sun Y; Servilla KS; Hartshorne MF; Tzamaloukas AH
    Adv Perit Dial; 2009; 25():68-71. PubMed ID: 19886320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.